AI-driven dermatology platform Cureskin secured $20 million in Series B funding led by HealthQuad with participation from JSW Ventures, Khosla Ventures, and Sharrp Ventures. The funds will enhance AI capabilities and expand solutions, following a $5 million Series A round. Having treated 1.5 million customers, mostly from tier 2 and 3 cities, Cureskin aims for growth. Diabetes-focused startup Sugar.fit raised an additional $5 million in Series A funding from B Capital, totaling $16 million. It plans to use funds to expand offerings and accelerate R&D in diabetes management after serving 30,000 users. Meanwhile, diagnostic provider Cardiotrack received $2 million in pre-Series A funding to advance its telemedicine kits and data analytics solutions.
Source link
Derma AI Cureskin bags $20M Series B funding and more funding from India
